Clinical Trial Update: Biomarkers to Enhance Early Schizophrenia Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating biomarkers to improve early treatment of schizophrenia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Northwell Health | Conditions: Schizophenia Disorder | Phase 4 | Status: NOT_YET_RECRUITING